[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341374-105":59,"doc-detail-341374-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","mirnas-and-microbiota-in-non-small-cell-lung-cancer-nsclc-implications-in-pathogenesis-and-potential-role-in-predicting-response-to-ici-treatment","MiRNAs and Microbiota in Non-Small Cell Lung Cancer (NSCLC) - Implications in Pathogenesis and Potential Role in Predicting Response to ICI Treatment","","Lung cancer remains among the most prevalent malignancies and is associated with high mortality, making prognostic biomarker discovery essential in non-small cell lung cancer (NSCLC). This review addresses how targeted therapies and immune checkpoint inhibitors (ICIs) have reshaped treatment in advanced and earlier stages, while emphasizing the emerging roles of micro-RNAs (miRNAs) and the lung/gut microbiota. MiRNAs, as non-coding RNAs, regulate proliferation, differentiation, inflammation, and apoptosis, whereas the microbiota modulates inflammatory and immune responses. Evidence indicates a bidirectional interaction in which microbiota-derived signals can affect miRNA expression and miRNAs can, in turn, influence microbiota-related signaling pathways implicated in NSCLC pathogenesis, supporting prediction of prognosis and ICI response.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mirnas-and-microbiota-in-non-small-cell-lung-cancer-nsclc-implications-in-pathogenesis-and-potential-role-in-predicting-response-to-ici-treatment/341374/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mirnas-and-microbiota-in-non-small-cell-lung-cancer-nsclc-implications-in-pathogenesis-and-potential-role-in-predicting-response-to-ici-treatment/341374.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"How does the miRNA–microbiome axis relate to predicting response to ICIs?","Question",{"text":112,"@type":113},"The evidence suggests that this axis is key for predicting prognosis and the effectiveness of ICIs in NSCLC treatment. It also points to potential interactions mediated by intracellular signaling pathways.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},341374,1790380242,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":137,"preview_page_count":19,"preview_urls":138},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Review  \nMiRNAs and Microbiota in Non-Small Cell Lung Cancer (NSCLC): Implications in Pathogenesis and Potential Role in Predicting Response to ICI Treatment  \nFrancesco Nucera 1,†, Paolo Ruggeri 1, *,†, Calogera Claudia Spagnolo 2, Mariacarmela Santarpia 2, Antonio Ieni 3, Francesco Monaco 4, Giovanni Tuccari 3, Giovanni Pioggia 5,‡ and Sebastiano Gangemi 6,‡  \nCitation: Nucera, F.; Ruggeri, P.; Spagnolo, C.C.; Santarpia, M.; Ieni, A.; Monaco, F.; Tuccari, G.; Pioggia, G.; Gangemi, S. MiRNAs and Microbiota in Non-Small Cell Lung Cancer (NSCLC): Implications in Pathogenesis and Potential Role in Predicting Response to ICI Treatment. Int. J. Mol. Sci. 2024, 25, 6685. [https://](https://)[ ](https://)[doi.org/10.3390/ijms25126685](doi.org/10.3390/ijms25126685)  \nAcademic Editor: Robert Arthur Kratzke  \nReceived: 21 May 2024  \nRevised: 13 June 2024  \nAccepted: 14 June 2024  \nPublished: 18 June 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Pneumologia, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università degli Studi di Messina, 98166 Messina, Italy; [francesco.nucera@unime.it](francesco.nucera@unime.it)  \n[2](2 Medical Oncology Unit)[ Medical Oncology Unit](2 Medical Oncology Unit), [Department of Human Pathology](Department of Human Pathology) “[G](G). Barresi”, University of Messina,  \n98122 Messina, Italy; [spagnoloclaudia92@gmail.com](spagnoloclaudia92@gmail.com) (C.C.S.); [mariacarmela.santarpia@unime.it](mariacarmela.santarpia@unime.it) (M.S.)  \n3 Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi”, Section of Anatomic Pathology, University of Messina, 98100 Messina, Italy; aieni@unime.it (A.I.); giovanni.tuccari@unime.it (G.T.)  \n4 Chirurgia Toracica, Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), Università degli Studi di Messina, 98166 Messina, Italy; [francesco.monaco@unime.it](francesco.monaco@unime.it)  \n5 Institute for Biomedical Research and Innovation (IRIB), National Research Council of Italy (CNR),  \n98164 Messina, Italy; [giovanni.pioggia@cnr.it](giovanni.pioggia@cnr.it)  \n6 Operative Unit of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria 1, 98125 Messina, Italy; [sebastiano.gangemi@unime.it](sebastiano.gangemi@unime.it)  \n* [Correspondence: paolo.ruggeri@unime.it](Correspondence: paolo.ruggeri@unime.it)[ ](Correspondence: paolo.ruggeri@unime.it)† These authors share the first author position.  \n‡ These authors share the last author position.  \nAbstract: Lung cancer (LC) is one of the most prevalent cancers in both men and women and today is still characterized by high mortality and lethality. Several biomarkers have been identified for evaluating the prognosis of non-small cell lung cancer (NSCLC) patients and selecting the most effective therapeutic strategy for these patients. The introduction of innovative targeted therapies and immunotherapy with immune checkpoint inhibitors (ICIs) for the treatment of NSCLC both in advanced stages and, more recently, also in early stages, has revolutionized and significantly improved the therapeutic scenario for these patients. Promising evidence has also been shown by analyzing both micro-RNAs (miRNAs) and the lung/gut microbiota. MiRNAs belong to the large family of non-coding RNAs and play a role in the modulation of several key mechanisms in cells such as proliferation, differentiation, inflammation, and apoptosis. On the other hand, the microbiota (a group of several microorganisms found in human orgasms such as the gut and lun","cbCaivxIYzrCBsaa","https://ap.wps.com/l/cbCaivxIYzrCBsaa","pdf",1088091,17,"English","# Introduction\n## Pathogenesis of NSCLC\n## Role of miRNAs and microbiota\n## Link to ICI response and prognosis","[{\"question\":\"How does the miRNA–microbiome axis relate to predicting response to ICIs?\",\"answer\":\"The evidence suggests that this axis is key for predicting prognosis and the effectiveness of ICIs in NSCLC treatment. It also points to potential interactions mediated by intracellular signaling pathways.\"}]","MiRNAs and Microbiota in Non-Small Cell Lung Cancer (NSCLC) - Implications in Pathogenesis and Potential Role in Predicting Response to ICI Treatment | PDF",1790041679,43,[139,143,147,151],{"page_no":8,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f750d8839f4d9390e6aa1508e1247b3.webp",983,1390,{"page_no":14,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dcee13dbadb5ff95a1123f23c7f34aab.webp",982,1388,{"page_no":81,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50be4c198db117d14e3b42eba1febc0d.webp",981,1387,{"page_no":19,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e326d874dc2c954f1d60509886f469e3.webp",980,1385]